Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Prospective validation of neonatal vancomycin dosing regimens is urgently needed.

Vandendriessche A, Allegaert K, Cossey V, Naulaers G, Saegeman V, Smits A.

Curr Ther Res Clin Exp. 2014 Jul 14;76:51-7. doi: 10.1016/j.curtheres.2014.06.001. eCollection 2014 Dec.

2.

Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.

Mehrotra N, Tang L, Phelps SJ, Meibohm B.

Pharmacotherapy. 2012 May;32(5):408-19. doi: 10.1002/j.1875-9114.2012.01029.x. Epub 2012 Apr 9.

PMID:
22488303
3.

Assessment of initial vancomycin dosing in neonates.

Dersch-Mills D, Bengry T, Akierman A, Alshaikh B, Yusuf K.

Paediatr Child Health. 2014 Jun;19(6):e30-4.

4.

Assessment of initial vancomycin dosing in neonates.

Dersch-Mills D, Bengry T, Akierman A, Alshaikh B, Yusuf K.

Paediatr Child Health. 2014 Jun;19(6):291.

5.

Vancomycin population pharmacokinetics in neonates.

de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN.

Clin Pharmacol Ther. 2000 Apr;67(4):360-7.

PMID:
10801244
6.

Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.

Zhao W, Lopez E, Biran V, Durrmeyer X, Fakhoury M, Jacqz-Aigrain E.

Arch Dis Child. 2013 Jun;98(6):449-53. doi: 10.1136/archdischild-2012-302765. Epub 2012 Dec 19.

PMID:
23254142
7.

Once-daily gentamicin dosing in newborn infants.

Lundergan FS, Glasscock GF, Kim EH, Cohen RS.

Pediatrics. 1999 Jun;103(6 Pt 1):1228-34.

PMID:
10353934
8.

Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ.

Pharmacotherapy. 2011 May;31(5):441-8. doi: 10.1592/phco.31.5.441.

PMID:
21923425
9.

Clinical pharmacokinetics of vancomycin in the neonate: a review.

Pacifici GM, Allegaert K.

Clinics (Sao Paulo). 2012 Jul;67(7):831-7. Review.

10.

Prospective Evaluation of a Model-Based Dosing Regimen for Amikacin in Preterm and Term Neonates in Clinical Practice.

Smits A, De Cock RF, Allegaert K, Vanhaesebrouck S, Danhof M, Knibbe CA.

Antimicrob Agents Chemother. 2015 Oct;59(10):6344-51. doi: 10.1128/AAC.01157-15. Epub 2015 Jul 27.

11.

Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.

Nielsen EI, Sandström M, Honoré PH, Ewald U, Friberg LE.

Clin Pharmacokinet. 2009;48(4):253-63. doi: 10.2165/00003088-200948040-00003.

PMID:
19492870
12.

Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 canadian teaching hospitals.

Thalakada R, Legal M, Lau TT, Luey T, Batterink J, Ensom MH.

Can J Hosp Pharm. 2012 May;65(3):180-7.

13.

Pharmacokinetic comparison of nomogram-based and individualized vancomycin regimens in neonates.

Crumby T, Rinehart E, Carby MC, Kuhl D, Talati AJ.

Am J Health Syst Pharm. 2009 Jan 15;66(2):149-53. doi: 10.2146/ajhp080121.

PMID:
19139479
14.

Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.

Anderson BJ, Allegaert K, Van den Anker JN, Cossey V, Holford NH.

Br J Clin Pharmacol. 2007 Jan;63(1):75-84. Epub 2006 Jul 21.

15.

Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.

Kim J, Walker SA, Iaboni DC, Walker SE, Elligsen M, Dunn MS, Allen VG, Simor A.

Antimicrob Agents Chemother. 2014 May;58(5):2830-40. doi: 10.1128/AAC.01718-13. Epub 2014 Mar 10.

16.

Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.

Eiland LS, Sonawane KB.

J Pediatr Pharmacol Ther. 2014 Jul;19(3):182-8. doi: 10.5863/1551-6776-19.3.182.

17.

Predictive Performance of a Vancomycin Population Pharmacokinetic Model in Neonates.

Stockmann C, Hersh AL, Roberts JK, Bhongsatiern J, Korgenski EK, Spigarelli MG, Sherwin CM, Frymoyer A.

Infect Dis Ther. 2015 Jun;4(2):187-98. doi: 10.1007/s40121-015-0067-9. Epub 2015 May 22.

18.

Tobramycin population pharmacokinetics in neonates.

de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN.

Clin Pharmacol Ther. 1997 Oct;62(4):392-9.

PMID:
9357390
19.

Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.

Irikura M, Fujiyama A, Saita F, Fukushima S, Kitaoka H, Fukuda T, Kawase A, Kondo Y, Ishitsuka Y, Kondo G, Maeda T, Yukawa E, Irie T.

Pediatr Int. 2011 Dec;53(6):1038-44. doi: 10.1111/j.1442-200X.2011.03441.x.

PMID:
21810150
20.

Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.

van Maarseveen EM, Sprij A, Touw DJ.

Ther Drug Monit. 2016 Jun;38(3):402-6. doi: 10.1097/FTD.0000000000000283.

PMID:
26836810
Items per page

Supplemental Content

Write to the Help Desk